Men’s urological needs refer to the medical and surgical conditions that affect the male urinary tract system and reproductive organs. Some of the common men’s urological needs include:
- Prostate health: The prostate is a gland located just below the bladder and is important for male reproductive health. Conditions such as benign prostatic hyperplasia (BPH) or prostate cancer can affect prostate health.
- Urinary tract infections (UTIs): UTIs are common in men and can cause pain and discomfort during urination. They are caused by bacterial infections in the urinary tract system.
- Erectile dysfunction: Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient for sexual intercourse. ED can be caused by several factors such as nerve damage, psychological issues, or underlying medical conditions.
- Infertility: Infertility is the inability to conceive a child. Male infertility can be caused by several factors such as low sperm count, poor sperm motility, or genetic conditions.
- Testicular health: Testicles are important for male reproductive health. Conditions such as testicular cancer, torsion, or trauma can affect testicular health.
- Incontinence: Incontinence is the loss of bladder control and can be caused by several factors such as prostate surgery, nerve damage, or medication side effects.
- Kidney stones: Kidney stones are hard deposits that form in the kidneys and can cause pain and discomfort during urination.
- Urological cancers: Men can develop several types of urological cancers, including prostate cancer, bladder cancer, and kidney cancer.
A urologist can address these concerns, however a pharmacy-led model of care developed by Brad Butt, called Mens Health Downunder has offered an alternative to certain urological needs of the male adult population over the past 10 years.
Initially commencing in Canberra and now in 9 locations across Australia, the operation is run by a group of Australian pharmacists that provide rehabilitation solutions and cost-effective endorsed medical grade treatments for men with urological health issues. Mens Health Downunder provides products that are medical grade and specifically tailored for individuals with urological or sexual health issues backed by evidence-based solutions and pharmaceutical advice.
Mens Health Downunder exists to address the growing need for men to access quality health advice, break the stigma around urological health and reduce the embarrassment so men openly ask questions and confidently address health concerns. No concern is off limits.
Australian Health Journal met with Brad to hear about his journey, Mens Health Downunder and the impact the pharmacy-led model of care has had on patient’s urological as well as mental health.
Brad’s mission is to also raise awareness for prostate cancer. Prostate cancer is now the most common cancer diagnosed in Australia with expectations of aggressive diagnosis to double by 2028, overtaking breast cancer. Interestingly, media tends to focus on breast cancer more than prostate cancer. Often this is because of the stigma associated with prostate cancer. Men suffer in silence and are less likely to seek medical diagnosis and treatment. However, the stigma that surrounds prostate cancer and men’s health is a significant barrier that is being addressed, by Brad and his team of pharmacists.
-
LIVED EXPERIENCE: severe aortic valve stenosis (aortic stenosis)
A Batemans Bay grandfather who dismissed months of breathlessness and fatigue as “just getting older” is now preparing to travel to Singapore to meet the technicians who hand-stitched the heart valve that helped save his life.
In April 2026, retired logistics courier, Geoff Lewis, 75, collapsed in front of his daughter and grandchildren while on holiday in Thailand, after months of symptoms he had ignored. The collapse would lead to a diagnosis of severe aortic stenosis and urgent treatment back home.
-
Research funded to investigate early-onset bowel cancer progression
Bowel Cancer Australia recently announced a team led by Professor Michael Samuel as the successful applicant for a three-year $600k early-onset bowel cancer research project through the 2023 round of Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS).
-
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy.
Australian Health Journal met with 3 speakers at the recent ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
